Efficacy and safety of everolimus plus exemestane in patients with hormone receptor‐positive, HER‐2‐negative advanced breast cancer: Results from the open‐label, multicentre, non‐interventional BRAWO study
The International Journal of Cancer is a cancer journal from the Union for International Cancer Control covering experimental and clinical cancer research.